The scientific congress entitled “Prostate cancer: current affairs and prospects”, organized by prof., will be held at the Dimiccoli hospital in Barletta, at the University Center of the ASL Bt, on Friday 5 and Saturday 6 July. Giuseppe Guglielmi, Full Professor of Radiology at the University of Foggia and Head of UOSVD Radiology at the Dimiccoli hospital in Barletta and prof. Luigi Cormio, professor of Urology at the University of Foggia and Director of the Urological and Andrological Unit of the Bonomo Hospital in Andria.
The congress, sponsored by the ASL Bt, includes five working sessions and will open on Friday 5 July at 8:30 am with institutional greetings from the General Director of the ASL Bt Tiziana Dimatteo and the Rector of the University of Foggia Lorenzo Lo Muzio.
Prostate cancer affects middle-aged men between the ages of 45 and 60 and is a leading cause of death in men globally, after lung disease.
There is no single specific test for prostate cancer, however, diagnosis is conventionally made by digital rectal examination (DRE). However, the prostate specific antigen (PSA) test remains the key to prostate cancer screening.
To confirm the presence of cancer, a biopsy of prostate tissue is usually performed. During the biopsy, the prostate gland is usually located with devices such as magnetic resonance imaging (MRI) and transrectal ultrasound (TRUS).
The treatment options available for prostate cancer are active surveillance, chemotherapy, radiotherapy, hormone therapy, surgery and cryotherapy. The treatment options provided to the patient depend on the nature of the tumor, PSA level, grade and stage, and possible recurrence.
